MIR

Analyst Note: Mirion Technologies, Inc. (MIR)

Date: 2026-06-13 Current Price: $18.61

1. Structural Readiness

State: Context-Only (Forming Coil)

• Conservative Entry: Not yet defined (awaiting confirmed breakout).
• Aggressive/Pre-Breakout Entry: N/A (Current price is not at a defined entry trigger for a confirmed breakout).
• Breakout Level: Not yet fired.
• Current Price: $18.61.
• Extension: Not applicable (price has not broken out to measure extension).
• ATR Context: Current ATR is 5.1% (High). This indicates elevated volatility, which is consistent with a "Growth Leader" archetype in a high-interest or high-activity sector.

2. Thesis Layer

Primary Secular Thesis: Energy Transition & Electrification → Grid & Transmission Modernization. Directness: High. Mirion is a direct beneficiary of the "Grid & Transmission Modernization" wave, specifically through the lens of Nuclear Power as a baseload solution.

Thesis Weighing: The company is positioned at the intersection of two powerful secular drivers:

• Nuclear Renaissance: Driven by the need for clean baseload power to support AI data centers and grid stability. Management explicitly cites "escalated energy needs created by cloud computing and artificial intelligence data centers" (E20) and "U.S. utilities have committed $1.4 trillion in planned capital expenditures through 2030" (E7).
• Medical Radiation Growth: A secondary, high-conviction theme where Mirion holds a dominant installed base.

The "Energy Transition" theme is the primary driver of the valuation rerating potential, as the market is re-pricing nuclear infrastructure from a "legacy utility" narrative to a "critical AI infrastructure" narrative. The company's role is not just as a supplier, but as a lifecycle partner (from new build to decommissioning), creating high switching costs and recurring revenue streams.

3. Business Overview

Industry: Industrials (Specialized Equipment & Services) Business Model: Mirion Technologies provides measurement, detection, and monitoring solutions for the nuclear and medical sectors. The business model is a hybrid of high-margin recurring services (installed base) and project-based engineering for new builds.

Key Business Metrics (as of Q1 2026):

• Revenue Growth: Q1 2026 revenue was $257.6 million, up from $202.0 million in Q1 2025, representing a 27.5% year-over-year increase (E13, E21).
• Order Book Strength: Orders increased 19% in Q1 to $241 million (excluding M&A growth) (E1).
• Backlog Visibility: Total backlog stands at $1.1 billion, up 19% excluding M&A (E2).
• Performance Obligations: Remaining performance obligations (RPO) were $1,120.6 million as of March 31, 2026 (E9).
• Revenue Recognition: Management expects to recognize approximately 36% of RPO in 2026, 20% in 2027, and 9% in 2028 (E10). This provides high visibility into the next 12-24 months.
• Segment Mix: The Nuclear & Safety segment generated 72.0% of revenue ($185.5M) in Q1 2026, while Medical generated 28.0% ($72.1M) (E13).
• Strategic Acquisitions: On December 1, 2025, Mirion acquired Paragon Energy Solutions for $588.4 million to expand its capabilities in the nuclear lifecycle (E16).
• Margin Expectations: Management continues to expect low 20s EBITDA margins (E6).
• Growth Drivers:
• Nuclear: "Greater than 80% of our Nuclear Power revenue accrues from the installed base" (E5). New nuclear projects (SMR and utility-scale) represent significant upside (E5).
• Medical: On track for double-digit organic revenue growth in 2026, the second consecutive year of such growth (E8).
• Large Orders: Secured $50 million in large opportunity orders in Q1 and an additional $35 million in SMR-related orders in April (E3).

4. Archetype and Conviction

Archetype: Growth Leader Fit: Mirion fits the "Growth Leader" archetype due to its ability to deliver double-digit organic growth in both core segments (Nuclear and Medical) while expanding its total addressable market through strategic M&A (Paragon). The company is not a cyclical recovery play; it is a structural growth story driven by secular demand for nuclear energy and medical radiation safety.

Conviction Stack:

• Thesis Strength: High. The alignment with AI-driven power demand and the $1.4T utility capex commitment provides a robust secular tailwind.
• Evidence Quality: Strong. The evidence base is rich with specific, quantitative data points (E1-E20) from earnings transcripts and SEC filings dated within the last 3 months. The backlog-to-revenue ratio is healthy, and order growth is accelerating.
• Structural Quality: High. The "low 20s EBITDA margin" expectation combined with 19% order growth suggests operating leverage is kicking in. The acquisition of Paragon adds scale and capability.
• Rerating Potential: Significant. As the market re-rates nuclear from a "safety risk" to "AI infrastructure," Mirion's valuation multiple could expand if it sustains its current growth trajectory.

5. Invalidation, Strengthening, and Gaps

What Would Invalidate:

• Fundamental: A significant miss in Q2 order growth or a degradation of the backlog conversion rate (e.g., RPO growth slowing significantly below the 36% recognition rate for 2026).
• Management: A downgrade of the "low 20s EBITDA margin" guidance or a delay in the integration of the Paragon acquisition.

What Would Strengthen:

• Technical: A confirmed breakout above the consolidation range (breakout level) with volume, followed by a retest of the breakout level as support.
• Fundamental: Confirmation of the "15% to 20% order growth" guidance for Q2 (E4) and the realization of the $35M SMR orders in April (E3).
• Macro: Further announcements of utility capex commitments or government incentives for nuclear power (E7, E15).

Gaps in Evidence:

• Specific Breakout Level: The exact price level for the breakout (the top of the consolidation range) is not provided in the evidence block, preventing a precise entry trigger calculation.
• Debt Service: While the Paragon acquisition ($588.4M) is noted, the specific impact on the balance sheet (debt load, interest coverage) is not detailed in the provided snippets, though the "low 20s margin" guidance implies management has factored this in.
• SMR Timeline: While SMR orders are won, the specific timeline for revenue recognition from these new SMR projects is not detailed beyond the general backlog visibility.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: Medium Key evidence: Q1 orders up 19% to $241M; Backlog at $1.1B with 36% recognized in 2026; Management expects 15-20% sequential order growth in Q2; Nuclear segment represents 72% of revenue with 80% recurring installed base. Key risks: Technical setup is forming, not confirmed; High ATR (5.1%) indicates elevated volatility; Paragon acquisition integration risks; Potential for utility capex delays. Sizing hint: Position size should reflect the "forming" status—smaller than a confirmed breakout, but larger than a speculative idea, scaling in on the breakout confirmation. Expected path: Management expects continued order growth and margin stability; structural demand from AI data centers and nuclear renaissance should drive backlog expansion; price likely consolidates before a breakout if the thesis holds. Expected horizon: 6 to 12 months for the thesis to fully play out as backlog converts to revenue.